RoslinCT and Lykan Bioscience, a combined cell therapy manufacturer, announced Tuesday it is adding six processing suites at its Hopkinton facility. Citing industry demand, the MetroWest and Edinburgh, Scotland based contract developer and manufacturing organization will now have 22 processing suites, with 14 in Hopkinton.
/PRNewswire/ RoslinCT and Lykan Bioscience, a leader in Contract Development and Manufacturing for cell therapies, announced the addition of six new cGMP.
/PRNewswire/ Aterian Investment Partners ("Aterian"), a private equity firm, announces that Salvatore Guccione has joined the Board of its portfolio company.
/PRNewswire/ Lykan Bioscience, an innovative contract development and manufacturing organization (CDMO) focused on cell-based therapies, today welcomes.